We found that these GRP78 inhibitors regressed pediatric and adult brain tumor neurospheres and eliminated receptor tyrosine kinase-like orphan receptor-1, Cripto, and programed death-ligand 1 expression, leading to tumor cell apoptosis. This evidence concerns the gene ROR1 and brain neoplasm.